相似文献
1
Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2002 Sep;46(9):3094-5. doi: 10.1128/AAC.46.9.3094-3095.2002.
2
In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.
J Antimicrob Chemother. 2002 Jul;50(1):89-93. doi: 10.1093/jac/dkf068.
3
In vitro activities of the oxazolidinone compounds linezolid (PNU-100766) and eperzolid (PNU-100592) against middle ear isolates of Streptococcus pneumoniae.
Int J Antimicrob Agents. 1999 Jul;12(2):141-4. doi: 10.1016/s0924-8579(99)00059-x.
4
In vivo pharmacodynamics of a new oxazolidinone (linezolid).
Antimicrob Agents Chemother. 2002 Nov;46(11):3484-9. doi: 10.1128/AAC.46.11.3484-3489.2002.
5
Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents.
J Antimicrob Chemother. 2002 Jul;50(1):95-100. doi: 10.1093/jac/dkf080.
6
In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates.
Antimicrob Agents Chemother. 2002 Aug;46(8):2662-4. doi: 10.1128/AAC.46.8.2662-2664.2002.
7
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.
Antimicrob Agents Chemother. 2003 Jun;47(6):1984-7. doi: 10.1128/AAC.47.6.1984-1987.2003.
8
In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
Diagn Microbiol Infect Dis. 1999 Jun;34(2):119-22. doi: 10.1016/s0732-8893(99)00016-4.
9
Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid.
Antimicrob Agents Chemother. 2003 Nov;47(11):3651-2. doi: 10.1128/AAC.47.11.3651-3652.2003.
10
In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae.
Antimicrob Agents Chemother. 1996 Apr;40(4):1039-40. doi: 10.1128/AAC.40.4.1039.
引用本文的文献
1
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.
Clin Microbiol Rev. 2021 Jun 16;34(3):e0018820. doi: 10.1128/CMR.00188-20. Epub 2021 Jun 2.
本文引用的文献
1
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
Lancet. 2001 Jul 21;358(9277):207-8. doi: 10.1016/S0140-6736(01)05410-1.
2
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
N Engl J Med. 2000 Dec 28;343(26):1917-24. doi: 10.1056/NEJM200012283432603.
3
Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.
Clin Infect Dis. 2000 Sep;31 Suppl 4:S144-9. doi: 10.1086/314080.
4
Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.
Clin Infect Dis. 2000 Aug;31(2):347-82. doi: 10.1086/313954. Epub 2000 Sep 7.
5
Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
Clin Infect Dis. 2000 Aug;31 Suppl 2:S29-34. doi: 10.1086/314057.
6
In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
Diagn Microbiol Infect Dis. 2000 Jun;37(2):93-8. doi: 10.1016/s0732-8893(00)00125-5.
7
Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors.
J Antimicrob Chemother. 2000 Jun;45(6):797-802. doi: 10.1093/jac/45.6.797.
8
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
Arch Intern Med. 2000 May 22;160(10):1399-408. doi: 10.1001/archinte.160.10.1399.
9
Activity of linezolid against multi-resistant gram-positive bacteria from diverse hospitals in the United Kingdom.
J Antimicrob Chemother. 2000 Feb;45(2):225-30. doi: 10.1093/jac/45.2.225.
10
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
Emerg Infect Dis. 1999 Nov-Dec;5(6):757-65. doi: 10.3201/eid0506.990603.
Zotero 插件